By combining the strength of molecular biology with next-generation sequencing, TRUSTlab is at the forefront of improving health care by detecting hereditary illnesses and describing genetic abnormalities that fuel cancer growth or monitoring disease outbreaks.
Technologies
- ● Rapid Qualitative (Lateral Flow Assays / Immunochromatography)
- ● Quantitative Assays (Enzyme-Linked Immunosorbent Assays – ELISAs)
- ● Chemiluminescent Immunoassay (CLIA)
- ● Autolumo1000 fully automated Random access analyzser
Specialized Tests
Serology tests are used to identify whether a person has had current or previous exposure to a disease. Antibodies that have been produced in response to disease are what these tests are looking for.
Types | What it tells | Limitation |
Rapid Serology Test | A qualitative determination of whether or not anti-virus antibodies are present in a patient's serum. | The number of antibodies present in a patient's serum or if these antibodies are capable of preventing viral development |
Enzyme-Linked Immunosorbent Assay (ELISA) | The quantity of antibodies to the virus present in the patient's serum, either present or absent. | If these antibodies are capable of preventing viral development |
Neutralization Assay | Active antibodies in the patient's serum that can stop a virus from growing ex vivo in a cell culture system. | It could overlook antibodies to viral proteins that are not involved in the replication |
Enhanced Chemiluminescent Immunoassay | The quantity of antibodies to the virus present in the patient's serum, either present or absent. | If these antibodies are capable of preventing viral development |